Cluster 133: concurrent agents investigational receiving therapy biological use chemotherapy radiation patients 
Cluster 305: anticancer concurrent therapy investigational approved agents treatment therapeutic therapeutics steroids 
Cluster 2013: concurrent therapy treatment protocol allowed cancer use radiation permitted investigational 
Cluster 2252: immunotherapy radiotherapy chemotherapy investigational therapy agents treatment prior days concurrent 
